Miura Kiyonori, Yoshiura Koh-Ichiro, Miura Shoko, Kondoh Tatsuro, Harada Naoki, Yamasaki Kentaro, Fujimoto Yoko, Yamasaki Yoko, Tanigawa Terumi, Kitajima Yuriko, Shimada Takako, Yoshida Atsushi, Nakayama Daisuke, Tagawa Masato, Yoshimura Shuichiro, Wagstaff Joseph, Jinno Yoshihiro, Ishimaru Tadayuki, Niikawa Norio, Masuzaki Hideaki
Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Am J Med Genet A. 2006 Sep 1;140A(17):1827-33. doi: 10.1002/ajmg.a.31389.
The purpose of this study was to know a role of confined placental mosaicism (CPM) in perinatal outcome and postnatal growth and development of infants with intrauterine growth restriction (IUGR). We selected 50 infants with IUGR (<-2.0 SD) from 3,257 deliveries in a regional medical center during the past 10-year period, and carried out cytogenetic and molecular analyses in their placenta and cord blood. Of the 50 infants, 8 had CPM (CPM group) and were composed of five single (CPM2, 7, 13, 22, and 22), one double (CPM7/13), and one quadruple trisomy (CPM2/7/15/20), and one partial monosomy [del(2)(p16)]. The origin of an extra chromosome of trisomy was maternal in six cases of CPM, paternal in one, and undetermined in one. Uniparental disomy in disomic cell lines was ruled out in all these mosaics. We also compared clinical parameters for perinatal outcome between CPM group and infants without evidence of CPM (non-CPM group), such as maternal and gestational age, birth weight, Apgar score, cord blood pH, gender, and uterine artery patterns by Doppler ultrasonography, as well as weight, height, and developmental quotient (DQ) by Denver Developmental Screening Test at age 12 months. Phenotypic abnormalities were noted in two infants with CPM and three infants of non-CPM group: One with CPM22 had ASD and hypospadias, one with CPM7/13 had Russell-Silver syndrome (RSS), and one without CPM had polydactyly, and two without CPM had RSS. All but one infant with CPM are alive at age 12 months. Among the clinical parameters, the detection rate of a notch waveform pattern of the uterine artery was significantly higher in the CPM group (P < 0.05). However, no significant difference was noted in perinatal outcome of pregnancy and in DQ at age 12 months between the two groups. Interestingly, short stature (<-2 SD) at age 12 months was more frequently seen in CPM group (7/8 infants with CPM vs. 8/15 infants without CPM), although no statistically significant difference was obtained. The information obtained will be useful for perinatal care and genetic counseling for infants with IUGR and CPM.
本研究的目的是了解局限性胎盘嵌合体(CPM)在宫内生长受限(IUGR)婴儿围产期结局及出生后生长发育中的作用。我们从一家地区医疗中心过去10年的3257例分娩中选取了50例IUGR(<-2.0 SD)婴儿,并对其胎盘和脐带血进行了细胞遗传学和分子分析。在这50例婴儿中,8例有CPM(CPM组),包括5例单体型(CPM2、7、13、22和22)、1例双体型(CPM7/13)、1例四体性三体(CPM2/7/15/20)和1例部分单体型[del(2)(p16)]。三体额外染色体的来源在6例CPM中为母源性,1例为父源性,1例未确定。所有这些嵌合体均排除了二倍体细胞系中的单亲二体。我们还比较了CPM组和无CPM证据的婴儿(非CPM组)围产期结局的临床参数,如母亲年龄和孕周、出生体重、阿氏评分、脐带血pH值、性别以及多普勒超声检查的子宫动脉模式,以及12个月龄时丹佛发育筛查测试的体重、身高和发育商(DQ)。CPM组有2例婴儿和非CPM组有3例婴儿出现表型异常:1例CPM22婴儿患有房间隔缺损和尿道下裂,1例CPM7/13婴儿患有罗素-西尔弗综合征(RSS),1例非CPM婴儿患有多指畸形,2例非CPM婴儿患有RSS。除1例CPM婴儿外,所有CPM婴儿在12个月龄时均存活。在临床参数中,CPM组子宫动脉切迹波形模式的检出率显著更高(P < 0.05)。然而,两组之间妊娠围产期结局和12个月龄时的DQ无显著差异。有趣的是,CPM组12个月龄时身材矮小(<-2 SD)更为常见(7/8例CPM婴儿 vs. 8/15例非CPM婴儿),尽管未获得统计学显著差异。所获得的信息将有助于为IUGR和CPM婴儿提供围产期护理和遗传咨询。